Oxomemazine Impurity 1 | CAS 67952-96-9 - Request Quote
Oxomemazine Impurity 1
| SZ CAT No: | SZ-O022003 |
| CAS No | 67952-96-9 |
| Mol.F. | C8H20N2 |
| Mol.Wt. | 144.3 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 2514685-87-9 (2HCl salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Oxomemazine Impurity 1 is chemically N1,N1,N3,N3,2-Pentamethylpropane-1,3-diamine. Oxomemazine Impurity 1 is supplied with detailed characterization data compliant with regulatory guideline. Oxomemazine Impurity 1 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Oxomemazine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 67952-96-9
Purchase 67952-96-9
Order 67952-96-9
Enquire 67952-96-9
price of 67952-96-9
67952-96-9 Supplier
67952-96-9 Manufacturer
67952-96-9 Exporter
buy high quality Oxomemazine Impurity 1
Purchase Oxomemazine Impurity 1
Oxomemazine Impurity 1 suppliers
Oxomemazine Impurity 1 manufacturers
Oxomemazine Impurity 1 price
Order Oxomemazine Impurity 1
Enquire Oxomemazine Impurity 1
Oxomemazine Impurity 1 cost
Oxomemazine Impurity 1 Supplier
Oxomemazine Impurity 1 Distributor
Oxomemazine Impurity 1 for Method Validation
Oxomemazine Reference Standard
Oxomemazine Impurity 1 for ANDA Filing
Oxomemazine Impurity 1 for Forced Degradation Studies
Oxomemazine Impurity 1 Identification Standards
Oxomemazine Impurity 1 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.